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Summary
Objective: To determine the seroprevalence of hepatitis E virus (HEV) infection among volunteer
blood donors in Khuzestan Province, Iran. Khuzestan is a war stricken area in the southwest of
Iran, which shares a land, river, and sea border with Iraq. This region has suffered the heaviest
public health system damage of all the Iranian provinces during a 25-year period of war and
conflict.
Methods: A cross-sectional study was carried out among 400 urban volunteer blood donors of the
regional blood banks, fromMay to December 2005. Serum samples from healthy blood donors were
tested for IgG anti-HEV antibody using a specific enzyme linked immunoassay (ELISA) kit.
Results: The prevalence of HEV infection was found to be 11.5% (46/400). All patients were
negative for anti-HIV, anti-HBV, and anti-HCV antibodies. The data indicate that 14.6% (38/260) of
HEV positive subjects were male, compared to 5.7% (8/140) of females; this difference is
statistically significant (risk ratio = 2.6, p < 0.008).
Conclusions: These findings demonstrate the high prevalence rate of anti-HEV among blood
donors, particularly males.
# 2007 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.Introduction
Hepatitis E virus (HEV) infection is the major cause of enteri-
cally transmitted non-A, non-B (NANB) hepatitis in many
parts of the world.1 This virus is well recognized as a cause* Corresponding author. Current address: Immunology Research
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doi:10.1016/j.ijid.2007.09.015of fulminant hepatic failure in areas where it is endemic,
particularly in pregnant women infected in the third trime-
ster.2,3 The infection has been shown to occur in both epi-
demic and sporadic forms and to be primarily associated with
the ingestion of fecally contaminated drinking water.1
Although they make only minor contributions to the spread
of the disease, other routes of transmission should not be
overlooked. For example, vertical transmission of HEV in
utero from infected mothers to their newborns has been
documented.4Published by Elsevier Ltd. All rights reserved.
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quite common in some areas of the world such as India,
Africa, and Southeast Asia, where it can represent the main
cause of acute hepatitis.5,6 Outbreaks of HEV infection have
been reported from Central and Southeast Asia. Therefore, it
is an important public health concern in many developing
countries of Southeast and Central Asia, the Middle East,
northern and western parts of Africa, and Mexico, where
outbreaks have been reported.5,7
Evidence is accumulating that shows HEV infection to be
an emerging disease in some developed countries as well.8,9
From studies of blood donors in developed countries, it would
appear that the prevalence of HEV in these countries is
around 3—5%.10—12
Conflicts and war have a devastating impact on public
health and the availability of safe and healthy food and
water. Therefore the prevalence of HEV is higher in these
areas; for example in Darfur, Sudan, the conflict has been
responsible for the largest outbreak of HEV documented in
the literature among internal displaced persons or refu-
gees.13,14 These studies have also shown that the most dra-
matic impact of this disease has been on pregnant women at
the community level.3,13,14
KhuzestanProvince, Iran, is located in the southwest of Iran
and shares a land, river, and sea border with Iraq. Khuzestan
has suffered the heaviest damage of all Iranian provinces
during a 25-year period including: the Iran—Iraq War (1980—
1988), the Gulf War (1990—1991), and the 10-year crisis in Iraq
(1992—2003). Moreover, the main river in the region (the
Karun) is the natural water source for piped and other water
supply systems, for drinking and household needs.
To our knowledge, few studies have addressed the pre-
valence of HEV infection in Iran, which has experienced a few
suspected outbreaks of HEV.15 The current study was con-
ducted to investigate the seroepidemiology of HEV among
blood donors in Khuzestan Province.
Methods
Study population
This cross-sectional study was performed fromMay to Decem-
ber 2005 in Khuzestan Province on first-time, volunteer,
healthy donors attending four regional blood banks in differ-
ent cities, for blood donation. A total of 400 serum samples
were collected from urban subjects. Blood samples were
taken after obtaining an informed consent, and the serum
samples obtained were then stored at 20 8C until anti-HEV
immunoglobulin G (IgG) assays were carried out.
All of the subjects were also screened for syphilis (rapid
plasma reagin (RPR) test), hepatitis B and C, and HIV type 1
and type 2 infections (ELISA test).Table 1 Prevalence of anti-HEV antibodies according to gender
Gender Anti-HEV positive n (%)
Male 38 (14.6)
Female 8 (5.7)
Total 46 (11.5)Laboratory assay
Sera from the study subjects, stored at 20 8C, were tested
by anti-HEV IgG assay with a commercial ELISA microplate kit
(HEV-EIA, Biokit, Spain) according to the manufacturer’s
instructions. The samples were considered positive when
the absorbance/cut-off (A/C) ratio was equal or higher to
1.0 and negative when the A/C ratio was <0.9 (values given
by the manufacturer).
Statistical analysis
Data comparisons were performed using the Chi-square test
with Fisher’s exact test. The differences were considered
significant if p < 0.05.
Results
Four hundred healthy blood donors were tested. There were
260 (65%) males and 140 (35%) females; their mean age was
33.3 years (range 18—60 years). Out of 400 subjects, 46
showed anti-HEV IgG antibodies; therefore the prevalence
of anti-HEV in our population was 11.5%. All patients were
negative for anti-HIV, anti-HBV, and anti-HCV antibodies.
Table 1 shows the distribution of anti-HEV reactivity in
healthy blood donors according to gender. These results
indicate that in the male group 14.6% (38/260) were HEV
positive compared to 5.7% (8/140) in the female group, a
difference that is statistically significant (risk ratio
(RR) = 2.6, p < 0.008).
Table 2 shows that 10.9% (28/258) of anti-HEV positive
subjects were under 35 years of age and 12.7% (18/142) were
over 35 years age. Therefore, a higher prevalence of anti-HEV
positivity was seen in the over-35 years age group.
Discussion
Although HEV infection is endemic in Southeast and Central
Asia, where several large outbreaks of hepatitis E have been
observed, sporadic hepatitis E occurrences have also been
observed in several countries where outbreaks have not been
reported, including Egypt and Turkey.16,17 There are few
reports on outbreaks of HEV in Iran,15 particularly for war
stricken areas. Zali et al.,18 in a population-based study,
indicated that the prevalence rate of IgG anti-HEV among
a healthy population in Iran was 9.6%. Taremi et al., in two
independent studies,19,20 reported the seroprevalence of
HEV in Tabriz, Northwest Iran and in hemodialysis patients
to be 7.8% and 7.4%, respectively.
In the present study the prevalence of anti-HEV IgG was
11.5% in urban healthy blood donors in Khuzestan Province,
Southwest Iran, an area with an approximate urban popula-in healthy blood donors
Anti-HEV negative n (%) Total n (%)
222 (85.4) 260 (100)
132 (94.3) 140 (100)
354 (88.5) 400 (100)
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Table 2 Prevalence of anti-HEV antibodies according to age in healthy blood donors
Age (years) Anti-HEV positive n (%) Anti-HEV negative n (%) Total n (%)
35 28 (10.9) 230 (89.1) 258 (100)
>35 18 (12.7) 124 (87.3) 142 (100)
Total 46 (11.5) 354 (88.5) 400 (100)tion of 2.8 million (Iran Census, 2006). The observation that
the anti-HEV prevalence rate in blood donors in our study
(11.5%) was higher than that found in the previous studies in
Iran,18,19 might be due to differences in the population, the
size of the sample, or the situation with regard to public
health services. However, the prevalence of anti-HEV IgG in
humans in our study was lower than that reported in studies
from other developing countries.2,6
Although, much about the epidemiology of hepatitis E is
unknown, outbreaks are most common in tropical and sub-
tropical regions of developing countries. Moreover, the out-
breaks and the HEV prevalence in these countries have been
associated with contaminated drinking water; river areas in
particular have been recognized as the foci of epidemic HEV
transmission.21,22 Khuzestan, the area under investigation in
the present study, is a tropical region, and the main river in
this province, Karun River, is the natural water source for the
piped water supply system providing drinking water and
water for household needs. However, the sewage from the
city, houses, and factories, is mainly disposed of in this river.
In addition, the Iran—Iraq War of 1980—1988, has had a
devastating impact on public health, financial resources, the
environment, and the availability of safe and healthy food
andwater in this war-stricken area. Moreover, during a period
of 15 years, due to poor security and living conditions, many
Iraqi refugees have crossed over the Iraqi border to Iran,
mainly to the southwestern regions. A significantly higher
prevalence of anti-HEV has been found among Iraqi refugees
(17.5%) compared to other immigrants to Western coun-
tries.23
It has been shown that conflicts have a devastating impact
on public health and the availability of healthy food and
water in war-stricken areas. In Darfur, Sudan, the conflict has
been responsible for a large outbreak of HEV among the
refugees.13,14 This impact of conflict might be explained
by the fact that an outbreak in a war-stricken area affects
people with an impaired health status because of poor living
conditions, extremely unsafe sanitary conditions, and poor
access to food.6,13
Taken together, open drains, the poor maintenance of the
sewerage disposal system, and the drinking water supply line
from the Karun River, and conflicts and emigration over a
period of 25 years, may have resulted in the high prevalence
of hepatitis E in Khuzestan Province.
The data in this study also indicate that 14.6% of males
were HEV positive compared to 5.7% of females; this differ-
ence is statistically significant (RR = 2.6, p < 0.008). This
means that male donors are more likely to be HEV positive
than female donors; however, the reasons for this pattern of
infection remain unclear. It could be that male exposure to
the sources of contamination is more frequent, perhaps due
to greater activity in the labor market, involvement in
high risk work in cleaning services or the sewerage disposalsystem, or compulsory military (national) service. This is a
controversial field that should be investigated further.
In conclusion, this cross-sectional study shows a high
prevalence of anti-HEV antibodies in our blood donors and
provides additional evidence that HEV is endemic in some
provinces of Iran. Furthermore, a careful surveillance in the
general population is required and further appropriate stu-
dies are needed to identify the exact mode of transmission
and risk groups for HEV infection in Iran.
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